VINC

Q: What is the price of Vincerx Pharma (VINC) today?

The current price of Vincerx Pharma (VINC) is $ 0.01, representing a -97.66% gain over the past year. The stock began the year trading around $ 0.01 and is currently priced at $ 0.01. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Vincerx Pharma (VINC) pay dividends?

Vincerx Pharma (VINC) did not pay dividends over the past year.

Vincerx Pharma Inc.

Price

$ 0.01

return (12m)

-97.66%

p/e

0.00

p/bv

0.03

DIVIDEND YIELD

0.00%

VINC price

VINC

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment VINC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.79%

3 months

-2.31%

1 year

-97.66%

2 years

-99.99%

5 years

-100.00%

10 years

0.00%

Fundamentals VINC

review the fundamentals of Vincerx Pharma shares

P/E

0.00

Sector: -3.90 Industry: -3.90

P/S (PSR)

Sector: -3.94 Industry: -3.94

P/BV

0.03

Sector: 1.83 Industry: 1.83

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-482.73%

Sector: -61.11% Industry: -61.11%

ROE

-1,093.72%

Sector: -61.17% Industry: -61.17%

ROIC

-831.94%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

0.00%

Sector: -39.18% Industry: -39.18%

GROSS MARGIN

0.00%

Sector: 38.38% Industry: 38.38%

OPERATING MARGIN

0.00%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

0.00

Sector: -3.73 Industry: -3.73

EV/EBIT

0.00

Sector: -3.95 Industry: -3.95

PRICE-TO-ASSETS

0.01

Sector: 1.35 Industry: 1.35

BVPS

0.52

Sector: 1.90 Industry: 1.90

EPS

-5.66

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.44

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.56

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-10.45%

Sector: - Industry: -

Fundamentals VINC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

VINC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Vincerx Pharma

Vincerx Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

7 years

Founded: 2019

2020

Time since IPO - 6 years

28

Employees

Vincerx Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $52.00 Thousand, with shareholders equity totaling $2.07 Millions.

The company employs approximately 28 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Vincerx Pharma Inc. reported $- in revenue, generating net income of $-22.64 Millions.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VINC.

Market cap

$ 52.00 Thousand

Net worth

$ 2.07 Millions

$ 2,070,000.00

Assets

$ 4.69 Millions

$ 4,690,000.00

Total Shares Outstanding

4.00 Millions

4,000,000

Average Daily Trading Volume

$ 5.87 Thousand

$ 5,873.66

Sector

Health Care

Industry

Biotechnology

VINC

VINC revenue and profits

Financial Results VINC

DRAG THE FRAME TO SEE MORE DATA

VINC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 856.62 28,02% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 212.77 65,55% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 238.41 62,32% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 27.10 29,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 206.37 19,49% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 119.28 50,91% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 200.81 57,55% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 856.62 28,02% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 212.77 65,55% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 238.41 62,32% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 27.10 29,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 206.37 19,49% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 119.28 50,91% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 200.81 57,55% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Vincerx Pharma (VINC) today?

The current price of Vincerx Pharma (VINC) is $ 0.01, representing a -97.66% gain over the past year. The stock began the year trading around $ 0.01 and is currently priced at $ 0.01. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Vincerx Pharma (VINC) pay dividends?

Vincerx Pharma (VINC) did not pay dividends over the past year.

Is Vincerx Pharma (VINC) a good investment?

Vincerx Pharma (VINC) is currently trading at $ 0.01 with a P/E ratio of 0.00%. This represents a -426% premium compared to its historical average P/E. Over the past year, the stock has gained -97.66 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -97.66%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vincerx Pharma (VINC) stock?

You can buy Vincerx Pharma (VINC) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol VINC and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Vincerx Pharma (VINC) yield today?

Over the past month, Vincerx Pharma (VINC) has returned 0.79% — -97.66% over the past year, and -100.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Vincerx Pharma (VINC) today at the current price of $ 0.01 your total investment would be $ 1.27.

Based on historical performance, the investment would have grown to approximately:

$ 0.03 after 1 year
$ 0.00 after 5 years
$ 1.27 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VINC

Vincerx Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VINC

review the fundamentals of Vincerx Pharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Vincerx Pharma

Vincerx Pharma Inc.

United States

7 years

2020

28

PROFIT X PRICE VINC

Financial Results VINC

VINC cash flow

Asset, Revenue and Profit Growth - VINC

VINC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions